Personalization of Pharmacological Treatments for ADHD: Why it is Advisable and Possible Options to Achieve it


Por: Herrera-Morales W.V., Ramirez-Lugo, Leticia, Cauich-Kumul, Roger, Murillo-Rodriguez, Eric, Núñez-Jaramillo L.

Publicada: 1 ene 2022
Resumen:
Attention-deficit hyperactivity disorder is a neurodevelopmental disorder diagnosed primarily in children, although it is also present in adults. Patients present inattention, impulsivity, and hyperactivity symptoms that create difficulties in their daily lives. Pharmacological treatment with stimulants or non-stimulants is used most commonly to reduce ADHD symptoms. Although generally effective and safe, pharmacological treatments have different effects among patients, including lack of response and adverse reactions. The reasons for these differences are not fully understood, but they may derive from the highly diverse etiology of ADHD. Strategies to guide optimal pharmacological treatment selection based on individual patients' physiological markers are being developed. In this review, we describe the main pharmacological ADHD treatments used and their main drawbacks. We present alternatives under study that would allow the customization of pharmacological treatments to overcome these drawbacks and achieve more reliable improvement of ADHD symptoms.

Filiaciones:
Herrera-Morales W.V.:
 Departamento de Ciencias Médicas, División de Ciencias de la Salud, Universidad de Quintana Roo, Quintana Roo, Chetumal, Mexico

Ramirez-Lugo, Leticia:
 Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Ciudad de México, Mexico

Cauich-Kumul, Roger:
 Departamento de Ciencias Farmaceúticas, División de Ciencias de la Salud, Universidad de Quintana Roo, Quintana Roo, Chetumal, Mexico

Murillo-Rodriguez, Eric:
 Laboratorio de Neurociencias Moleculares e Integrativas, Escuela de Medi-cina, División Ciencias de la Salud, Universidad Anáhuac Mayab, Mérida, Mexico

 Intercontinental Neuroscience Research Group, Yucatán, Mérida, Mexico

Núñez-Jaramillo L.:
 Departamento de Ciencias Médicas, División de Ciencias de la Salud, Universidad de Quintana Roo, Quintana Roo, Chetumal, Mexico
ISSN: 15680266





CURRENT TOPICS IN MEDICINAL CHEMISTRY
Editorial
BENTHAM SCIENCE PUBL LTD, EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES
Tipo de documento: Review
Volumen: 22 Número: 15
Páginas: 1236-1249
WOS Id: 000850086400004
ID de PubMed: 35579123